George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 20,030 shares at $1.46 ($29K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Scheduled sale ($29k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $16K | — | Filing → |